Royal jellies (RJs) possess moisturizing, emulsifying, and stabilizing properties, and a number of pharmacological actions have additionally been discovered to be current, which make them a perfect element for cosmetic and skincare products. Nevertheless, regardless of the considerable efficacies, there’s a lack of research that discover the chemical composition of RJ utilizing metabolome analysis.
Moreover, an analysis of the chemical composition of Indonesian RJs collected from completely different areas has but to be carried out. Due to this fact, the fundamental goal of this examine was to determine any variations in the chemical composition of such RJs. Chemical profiling was additionally carried out to allow extra focused utilization primarily based on the precise compositions.
Chemical profiling can be essential given the wealthy Indonesian biodiversity and the excessive dependence of the RJ compositions on the botanical supply. On this analysis, ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry was used as half of an untargeted metabolomics method.
From the chemical profiling, >30 compounds have been recognized throughout 4 RJ samples. The key constituents of the samples have been discovered to be oligosaccharides, fatty acids, and adenosine monophosphate derivatives. In the meantime, sucrose and planteose have been discovered to be highest in the samples from Banjarnegara and Kediri, whereas dimethyloctanoic acid was discovered to be distinctive to the pattern from Banjarnegara.
It was additionally found that the RJs from Demak and Tuban contained extra natural fatty acids and oligosaccharides than the different samples. Though the pattern from Demak demonstrated good potential for use in the cosmetic, skincare, and bio-supplement industries, the larger abundance of fatty acids and oligosaccharides in the pattern from Tuban indicated that it’s maybe the best suited RJ for use on this discipline.
Information Mining Approaches for Assessing Chemical Coexposures Utilizing Shopper Product Buy Information
The use of shopper products presents a possible for chemical exposures to people. Toxicity testing and publicity fashions are routinely employed to estimate dangers from their use; nevertheless, a key problem is the sparseness of info regarding who makes use of products and which products are used contemporaneously.
Our objective was to display a way to deduce use patterns by method of buy knowledge. We examined buy patterns for three varieties of private care products (cosmetics, hair care, and skincare) and two family care products (family cleaners and laundry provides) utilizing knowledge from 60,000 households collected over a one-year interval in 2012.
The market basket analysis methodology frequent itemset mining (FIM) was used to determine co-occurring units of product purchases for all households and demographic teams primarily based on revenue, training, race/ethnicity, and household composition. Our methodology captured strong co-occurrence patterns for private and family products, globally and for completely different demographic teams.
FIM recognized cosmetic co-occurrence patterns captured in prior surveys of cosmetic use, as properly as a pattern of elevated variety of cosmetic purchases as youngsters mature to teenage years. We suggest that shopper product buy knowledge may be mined to tell person-oriented use patterns for high-throughput chemical screening purposes, for mixture and mixed chemical danger evaluations.
Chemical Elimination of Lead Corrosion Products
Restoration therapy, specimen preparation or mass loss measurements on coupons made of lead require a dependable course of of dissolution of corrosion products. On this examine, a number of varieties of mannequin corrosion products with compositions consultant of these discovered on actual objects have been ready and characterised.
Ten options have been then totally examined in interval cleansing experiments, relating to the effectivity of removing of the corrosion products, corrosivity in the direction of naked lead, and remnants left on the floor. The answer advisable in the present model of the ISO 8470 customary was discovered to be improper for the cleansing of each historic artefacts and corrosion coupons attributable to its incapability to take away sulfide corrosion products and the danger of floor contamination and staining.
An answer of 20% hydrochloric acid is the best option for the preparation of lead coupons earlier than publicity or for analysis of mass loss of uncovered samples as a result of its considerably larger corrosivity in the direction of metallic lead is tolerable for these purposes.
Rochelle salt answer was discovered to be optimum for the cleansing of historic artefacts free of sulfide corrosion products attributable to the lowest corrosivity. None of these various options depart remnants on the floor and they’re environment friendly at laboratory temperature.
Figuring out Risky Chemical Product Tracer Compounds in U.S. Cities
With visitors emissions of risky natural compounds (VOCs) reducing quickly over the final a long time, the contributions of the emissions from different supply classes, such as risky chemical products (VCPs), have turn out to be extra obvious in city air. On this work, in situ measurements of numerous VOCs are reported for New York Metropolis, Pittsburgh, Chicago, and Denver.
The magnitude of completely different emission sources relative to visitors is set by measuring the city enhancement of particular person compounds relative to the enhancement of benzene, a recognized tracer of fossil gas in the United States. The enhancement ratios of a number of VCP compounds to benzene correlate properly with inhabitants density (R2 ∼ 0.6-0.8).
These observations are in keeping with the expectation that some human exercise ought to correlate higher with the inhabitants density than transportation emissions, attributable to the decrease per capita fee of driving in denser cities. Utilizing these knowledge, along with a bottom-up fuel-based stock of car emissions and risky chemical products (FIVE-VCP) stock, we determine tracer compounds for completely different VCP classes: decamethylcyclopentasiloxane (D5-siloxane) for private care products, monoterpenes for fragrances, p-dichlorobenzene for pesticides, D4-siloxane for adhesives, para-chlorobenzotrifluoride (PCBTF) for solvent-based coatings, and Texanol for water-based coatings.
METHYL HYDRAZINE HCL |
|||
| 913019 | Survival Technologies | each | Ask for price |
3-Methoxytyramine · HCl |
|||
| Q-1330.0001 | Bachem | 1.0g | 181.2 EUR |
|
Description: Sum Formula: C9H13NO2·HCl; CAS# [1477-68-5] |
|||
3-Methoxytyramine · HCl |
|||
| Q-1330.0005 | Bachem | 5.0g | 618 EUR |
|
Description: Sum Formula: C9H13NO2·HCl; CAS# [1477-68-5] |
|||
HCl Dilution Matrix (10g/l HCl) |
|||
| HADM1 | Scientific Laboratory Supplies | 1L | 134.4 EUR |
HCl Dilution Matrix 10g/L HCl |
|||
| HADM1A | Scientific Laboratory Supplies | 2ML | 122.73 EUR |
(R)-2-Methylcysteine HCl |
|||
| A8912-10 | ApexBio | 10 mg | 259.2 EUR |
|
Description: (R)-2-Methylcysteine HCl |
|||
(R)-2-Methylcysteine HCl |
|||
| A8912-50 | ApexBio | 50 mg | 861.6 EUR |
|
Description: (R)-2-Methylcysteine HCl |
|||
ML133 HCl |
|||
| B2199-10 | ApexBio | 10 mg | 150 EUR |
|
Description: ML133 is a selective potassium channel inhibitor for Kir2.1 with IC50 of 1.8 ?M (pH 7.4) and 290 nM (pH 8.5), has no effect on Kir1.1 and weak activity for Kir4.1 and Kir7.1. |
|||
ML133 HCl |
|||
| B2199-25 | ApexBio | 25 mg | 274.8 EUR |
|
Description: ML133 is a selective potassium channel inhibitor for Kir2.1 with IC50 of 1.8 ?M (pH 7.4) and 290 nM (pH 8.5), has no effect on Kir1.1 and weak activity for Kir4.1 and Kir7.1. |
|||
ML133 HCl |
|||
| B2199-5 | ApexBio | 5 mg | 129.6 EUR |
|
Description: ML133 is a selective potassium channel inhibitor for Kir2.1 with IC50 of 1.8 ?M (pH 7.4) and 290 nM (pH 8.5), has no effect on Kir1.1 and weak activity for Kir4.1 and Kir7.1. |
|||
ML133 HCl |
|||
| B2199-50 | ApexBio | 50 mg | 420 EUR |
|
Description: ML133 is a selective potassium channel inhibitor for Kir2.1 with IC50 of 1.8 ?M (pH 7.4) and 290 nM (pH 8.5), has no effect on Kir1.1 and weak activity for Kir4.1 and Kir7.1. |
|||
ML133 HCl |
|||
| B2199-S | ApexBio | Evaluation Sample | 97.2 EUR |
|
Description: ML133 is a selective potassium channel inhibitor for Kir2.1 with IC50 of 1.8 ?M (pH 7.4) and 290 nM (pH 8.5), has no effect on Kir1.1 and weak activity for Kir4.1 and Kir7.1. |
|||
LX7101 HCL |
|||
| B5863-10 | ApexBio | 10 mg | 927.6 EUR |
|
Description: Description:IC50: 4.3, 32, 69 and 32 nM for LIMK2, KIMK1, ROCK1 and ROCK2, respectivleyLIM-kinases 1 and 2 (LIMK1 and LIMK2) regulate cytoskeletal dynamics by phosphorylating and deactivating cofilin, a protein that depolymerizes actin filaments. |
|||
LX7101 HCL |
|||
| B5863-100 | ApexBio | 100 mg | 4837.2 EUR |
|
Description: Description:IC50: 4.3, 32, 69 and 32 nM for LIMK2, KIMK1, ROCK1 and ROCK2, respectivleyLIM-kinases 1 and 2 (LIMK1 and LIMK2) regulate cytoskeletal dynamics by phosphorylating and deactivating cofilin, a protein that depolymerizes actin filaments. |
|||
LX7101 HCL |
|||
| B5863-5 | ApexBio | 5 mg | 582 EUR |
|
Description: Description:IC50: 4.3, 32, 69 and 32 nM for LIMK2, KIMK1, ROCK1 and ROCK2, respectivleyLIM-kinases 1 and 2 (LIMK1 and LIMK2) regulate cytoskeletal dynamics by phosphorylating and deactivating cofilin, a protein that depolymerizes actin filaments. |
|||
LX7101 HCL |
|||
| B5863-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 576 EUR |
|
Description: Description:IC50: 4.3, 32, 69 and 32 nM for LIMK2, KIMK1, ROCK1 and ROCK2, respectivleyLIM-kinases 1 and 2 (LIMK1 and LIMK2) regulate cytoskeletal dynamics by phosphorylating and deactivating cofilin, a protein that depolymerizes actin filaments. |
|||
LX7101 HCL |
|||
| B5863-50 | ApexBio | 50 mg | 3099.6 EUR |
|
Description: Description:IC50: 4.3, 32, 69 and 32 nM for LIMK2, KIMK1, ROCK1 and ROCK2, respectivleyLIM-kinases 1 and 2 (LIMK1 and LIMK2) regulate cytoskeletal dynamics by phosphorylating and deactivating cofilin, a protein that depolymerizes actin filaments. |
|||
GW3965 HCl |
|||
| A8444-10 | ApexBio | 10 mg | 205.2 EUR |
|
Description: GW3965 HCl is a selective, orally active non-steroidal agonist for the liver X receptor (LXR) [1].Nuclear receptors LXR? and LXR? have an important role in control of cholesterol and fatty acid metabolism in multiple cell types. |
|||
GW3965 HCl |
|||
| A8444-5 | ApexBio | 5 mg | 154.8 EUR |
|
Description: GW3965 HCl is a selective, orally active non-steroidal agonist for the liver X receptor (LXR) [1].Nuclear receptors LXR? and LXR? have an important role in control of cholesterol and fatty acid metabolism in multiple cell types. |
|||
GW3965 HCl |
|||
| A8444-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 199.2 EUR |
|
Description: GW3965 HCl is a selective, orally active non-steroidal agonist for the liver X receptor (LXR) [1].Nuclear receptors LXR? and LXR? have an important role in control of cholesterol and fatty acid metabolism in multiple cell types. |
|||
GW3965 HCl |
|||
| A8444-50 | ApexBio | 50 mg | 614.4 EUR |
|
Description: GW3965 HCl is a selective, orally active non-steroidal agonist for the liver X receptor (LXR) [1].Nuclear receptors LXR? and LXR? have an important role in control of cholesterol and fatty acid metabolism in multiple cell types. |
|||
Doxepin HCl |
|||
| 20-abx184015 | Abbexa |
|
|
Ozagrel HCl |
|||
| B2116-10 | ApexBio | 10 mg | 153.6 EUR |
|
Description: Ozagrel HCl |
|||
Ozagrel HCl |
|||
| B2116-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: Ozagrel HCl |
|||
Ozagrel HCl |
|||
| B2116-50 | ApexBio | 50 mg | 265.2 EUR |
|
Description: Ozagrel HCl |
|||
Ozagrel HCl |
|||
| B2116-S | ApexBio | Evaluation Sample | 97.2 EUR |
|
Description: Ozagrel HCl |
|||
Scopine HCl |
|||
| B2130-100 | ApexBio | 100 mg | 517.2 EUR |
|
Description: Scopine HCl |
|||
Scopine HCl |
|||
| B2130-25 | ApexBio | 25 mg | 201.6 EUR |
|
Description: Scopine HCl |
|||
Scopine HCl |
|||
| B2130-S | ApexBio | Evaluation Sample | 97.2 EUR |
|
Description: Scopine HCl |
|||
Adenine HCl |
|||
| B1471-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 170.4 EUR |
|
Description: Adenine HCl, a purine derivative and a nucleobase, plays crucial roles in substantial biochemistry processes in vivo, including cellular respiration, formation of the energy-rich adenosine triphosphate (ATP), the cofactors nicotinamide adenine dinucleotide (NAD) and flavin adenine dinucleotide. |
|||
Adenine HCl |
|||
| B1471-50 | ApexBio | 50 mg | 153.6 EUR |
|
Description: Adenine HCl, a purine derivative and a nucleobase, plays crucial roles in substantial biochemistry processes in vivo, including cellular respiration, formation of the energy-rich adenosine triphosphate (ATP), the cofactors nicotinamide adenine dinucleotide (NAD) and flavin adenine dinucleotide. |
|||
Adenine HCl |
|||
| B1471-S | ApexBio | Evaluation Sample | 97.2 EUR |
|
Description: Adenine HCl, a purine derivative and a nucleobase, plays crucial roles in substantial biochemistry processes in vivo, including cellular respiration, formation of the energy-rich adenosine triphosphate (ATP), the cofactors nicotinamide adenine dinucleotide (NAD) and flavin adenine dinucleotide. |
|||
SRT1720 HCl |
|||
| A4180-10 | ApexBio | 10 mg | 309.6 EUR |
|
Description: SRT1720 is a small-molecule compound which has the ability of activating the sirtuin subtype SIRT1 in vitro. The activity of SRT1720 as a SIRT1 activator is stronger than that of resveratrol. |
|||
SRT1720 HCl |
|||
| A4180-200 | ApexBio | 200 mg | 1730.4 EUR |
|
Description: SRT1720 is a small-molecule compound which has the ability of activating the sirtuin subtype SIRT1 in vitro. The activity of SRT1720 as a SIRT1 activator is stronger than that of resveratrol. |
|||
SRT1720 HCl |
|||
| A4180-5 | ApexBio | 5 mg | 212.4 EUR |
|
Description: SRT1720 is a small-molecule compound which has the ability of activating the sirtuin subtype SIRT1 in vitro. The activity of SRT1720 as a SIRT1 activator is stronger than that of resveratrol. |
|||
SRT1720 HCl |
|||
| A4180-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 226.8 EUR |
|
Description: SRT1720 is a small-molecule compound which has the ability of activating the sirtuin subtype SIRT1 in vitro. The activity of SRT1720 as a SIRT1 activator is stronger than that of resveratrol. |
|||
SRT1720 HCl |
|||
| A4180-50 | ApexBio | 50 mg | 825.6 EUR |
|
Description: SRT1720 is a small-molecule compound which has the ability of activating the sirtuin subtype SIRT1 in vitro. The activity of SRT1720 as a SIRT1 activator is stronger than that of resveratrol. |
|||
SRT1720 HCl |
|||
| A4180-S | ApexBio | Evaluation Sample | 97.2 EUR |
|
Description: SRT1720 is a small-molecule compound which has the ability of activating the sirtuin subtype SIRT1 in vitro. The activity of SRT1720 as a SIRT1 activator is stronger than that of resveratrol. |
|||
ADL5859 HCl |
|||
| A2986-100 | ApexBio | 100 mg | 1423.2 EUR |
|
Description: Selective ? opioid receptor agonists are promising potential therapeutic agents for the treatment of various types of pain conditions. A spirocyclic derivative was identified as a promising hit through screening. |
|||
ADL5859 HCl |
|||
| A2986-25 | ApexBio | 25 mg | 588 EUR |
|
Description: Selective ? opioid receptor agonists are promising potential therapeutic agents for the treatment of various types of pain conditions. A spirocyclic derivative was identified as a promising hit through screening. |
|||
ADL5859 HCl |
|||
| A2986-5 | ApexBio | 5 mg | 226.8 EUR |
|
Description: Selective ? opioid receptor agonists are promising potential therapeutic agents for the treatment of various types of pain conditions. A spirocyclic derivative was identified as a promising hit through screening. |
|||
ADL5859 HCl |
|||
| A2986-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 261.6 EUR |
|
Description: Selective ? opioid receptor agonists are promising potential therapeutic agents for the treatment of various types of pain conditions. A spirocyclic derivative was identified as a promising hit through screening. |
|||
Esmolol HCl |
|||
| B1748-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: Esmolol is a cardioselective b-blocker, used to control rapid heartbeats or abnormal heart rhythms. |
|||
Esmolol HCl |
|||
| B1748-50 | ApexBio | 50 mg | 153.6 EUR |
|
Description: Esmolol is a cardioselective b-blocker, used to control rapid heartbeats or abnormal heart rhythms. |
|||
Nefopam HCl |
|||
| B1794-10 | ApexBio | 10 mg | 142.8 EUR |
|
Description: Nefopam HCl is an centrally-acting but non-opioid analgesic drug by blocking voltage-gated sodium channel and inhibition of serotonin, dopamine and noradrenaline reuptake. |
|||
Nefopam HCl |
|||
| B1794-5.1 | ApexBio | 10 mM (in 1mL H2O) | 158.4 EUR |
|
Description: Nefopam HCl is an centrally-acting but non-opioid analgesic drug by blocking voltage-gated sodium channel and inhibition of serotonin, dopamine and noradrenaline reuptake. |
|||
Nefopam HCl |
|||
| B1794-50 | ApexBio | 50 mg | 208.8 EUR |
|
Description: Nefopam HCl is an centrally-acting but non-opioid analgesic drug by blocking voltage-gated sodium channel and inhibition of serotonin, dopamine and noradrenaline reuptake. |
|||
Arbidol HCl |
|||
| A8362-10 | ApexBio | 10 mg | 129.6 EUR |
|
Description: Arbidol (Umifenovir) hydrochloride is an broad-spectrum antiviral chemical agent which can inhibit cell entry of enveloped viruses by blocking viral fusion with host cell membrane. |
|||
Arbidol HCl |
|||
| A8362-100 | ApexBio | 100 mg | 421.2 EUR |
|
Description: Arbidol (Umifenovir) hydrochloride is an broad-spectrum antiviral chemical agent which can inhibit cell entry of enveloped viruses by blocking viral fusion with host cell membrane. |
|||
Arbidol HCl |
|||
| A8362-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 135.6 EUR |
|
Description: Arbidol (Umifenovir) hydrochloride is an broad-spectrum antiviral chemical agent which can inhibit cell entry of enveloped viruses by blocking viral fusion with host cell membrane. |
|||
Ambroxol Hcl |
|||
| abx188586-250g | Abbexa | 250 g | 309.6 EUR |
Pd128907 Hcl |
|||
| 20-abx184299 | Abbexa |
|
|
Procaine HCl |
|||
| 20-abx184762 | Abbexa |
|
|
Thiamine HCl |
|||
| 20-abx184786 | Abbexa |
|
|
Prazosin HCl |
|||
| 20-abx185996 | Abbexa |
|
|
GW791343 HCl |
|||
| B2165-10 | ApexBio | 10 mg | 320.4 EUR |
|
Description: GW791343 is a P2X7 allosteric modulator. Exhibits species-specific activity and acts as a negative allosteric modulator of human P2X7 (pIC50 = 6.9 - 7.2). A positive allosteric modulator of rat P2X7. |
|||
GW791343 HCl |
|||
| B2165-5 | ApexBio | 5 mg | 211.2 EUR |
|
Description: GW791343 is a P2X7 allosteric modulator. Exhibits species-specific activity and acts as a negative allosteric modulator of human P2X7 (pIC50 = 6.9 - 7.2). A positive allosteric modulator of rat P2X7. |
|||
GW791343 HCl |
|||
| B2165-50 | ApexBio | 50 mg | 884.4 EUR |
|
Description: GW791343 is a P2X7 allosteric modulator. Exhibits species-specific activity and acts as a negative allosteric modulator of human P2X7 (pIC50 = 6.9 - 7.2). A positive allosteric modulator of rat P2X7. |
|||
Urapidil HCl |
|||
| B2242-50 | ApexBio | 50 mg | 153.6 EUR |
|
Description: Urapidil HCl is an ?1-adrenoceptor antagonist and 5-HT1A receptor agonist. |
|||
Urapidil HCl |
|||
| B2242-S | ApexBio | Evaluation Sample | 97.2 EUR |
|
Description: Urapidil HCl is an ?1-adrenoceptor antagonist and 5-HT1A receptor agonist. |
|||
SB269970 HCl |
|||
| B2254-10 | ApexBio | 10 mg | 297.6 EUR |
|
Description: SB269970 HCl is a potent and selective antagonist of 5-HT7 receptor with pKi value of 8.3 [1].SB269970 is a selective antagonist of 5-HT7 receptor. It shows at least 100-fold selective against 5-HT7 over a variety of receptors and enzymes |
|||
SB269970 HCl |
|||
| B2254-25 | ApexBio | 25 mg | 591.6 EUR |
|
Description: SB269970 HCl is a potent and selective antagonist of 5-HT7 receptor with pKi value of 8.3 [1].SB269970 is a selective antagonist of 5-HT7 receptor. It shows at least 100-fold selective against 5-HT7 over a variety of receptors and enzymes |
|||
SB269970 HCl |
|||
| B2254-5 | ApexBio | 5 mg | 184.8 EUR |
|
Description: SB269970 HCl is a potent and selective antagonist of 5-HT7 receptor with pKi value of 8.3 [1].SB269970 is a selective antagonist of 5-HT7 receptor. It shows at least 100-fold selective against 5-HT7 over a variety of receptors and enzymes |
|||
SB269970 HCl |
|||
| B2254-50 | ApexBio | 50 mg | 999.6 EUR |
|
Description: SB269970 HCl is a potent and selective antagonist of 5-HT7 receptor with pKi value of 8.3 [1].SB269970 is a selective antagonist of 5-HT7 receptor. It shows at least 100-fold selective against 5-HT7 over a variety of receptors and enzymes |
|||
Ambroxol HCl |
|||
| B2267-50 | ApexBio | 50 mg | 129.6 EUR |
|
Description: AmbroxolHCl is a potent inhibitor of the neuronal Na+ channels, inhibits TTX-resistant Na+ currents with IC50 of 35.2 ?M and 22.5 ?M for tonic and phasic block, inhibits TTX-sensitive Na+ currents with IC50 of 100 ?M. Phase 3. |
|||
Ambroxol HCl |
|||
| B2267-S | ApexBio | Evaluation Sample | 97.2 EUR |
|
Description: AmbroxolHCl is a potent inhibitor of the neuronal Na+ channels, inhibits TTX-resistant Na+ currents with IC50 of 35.2 ?M and 22.5 ?M for tonic and phasic block, inhibits TTX-sensitive Na+ currents with IC50 of 100 ?M. Phase 3. |
|||
Procaine HCl |
|||
| B2273-50 | ApexBio | 50 mg | 153.6 EUR |
|
Description: Procaine is an inhibitor of sodium channel, NMDA receptor and nAChR with IC50 of 60 ?M, 0.296 mM and 45.5 ?M, which is also an inhibitor of 5-HT3 with KD of 1.7 ?M. |
|||
Procaine HCl |
|||
| B2273-S | ApexBio | Evaluation Sample | 97.2 EUR |
|
Description: Procaine is an inhibitor of sodium channel, NMDA receptor and nAChR with IC50 of 60 ?M, 0.296 mM and 45.5 ?M, which is also an inhibitor of 5-HT3 with KD of 1.7 ?M. |
|||
Xylazine HCl |
|||
| B1351-100 | ApexBio | 100 mg | 129.6 EUR |
|
Description: Xylazine HCl is a strong agonist of ?2-adrenoceptor [1]. Xylazine HCl has been reported to stimulate the proliferation of rat thymocytes in vivo (at doses of 2.5 mg/kg and 5 mg/kg) and in vitro (at concentration of 5 mM) [2]. |
|||
Xylazine HCl |
|||
| B1351-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 135.6 EUR |
|
Description: Xylazine HCl is a strong agonist of ?2-adrenoceptor [1]. Xylazine HCl has been reported to stimulate the proliferation of rat thymocytes in vivo (at doses of 2.5 mg/kg and 5 mg/kg) and in vitro (at concentration of 5 mM) [2]. |
|||
Xylazine HCl |
|||
| B1351-500 | ApexBio | 500 mg | 184.8 EUR |
|
Description: Xylazine HCl is a strong agonist of ?2-adrenoceptor [1]. Xylazine HCl has been reported to stimulate the proliferation of rat thymocytes in vivo (at doses of 2.5 mg/kg and 5 mg/kg) and in vitro (at concentration of 5 mM) [2]. |
|||
Xylazine HCl |
|||
| B1351-S | ApexBio | Evaluation Sample | 97.2 EUR |
|
Description: Xylazine HCl is a strong agonist of ?2-adrenoceptor [1]. Xylazine HCl has been reported to stimulate the proliferation of rat thymocytes in vivo (at doses of 2.5 mg/kg and 5 mg/kg) and in vitro (at concentration of 5 mM) [2]. |
|||
Dopamine HCl |
|||
| B1482-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 170.4 EUR |
|
Description: Dopamine HCl is a catecholamine neurotransmitter present in a wide variety of animals,And a dopamine D1-5 receptors agonist. |
|||
Dopamine HCl |
|||
| B1482-50 | ApexBio | 50 mg | 153.6 EUR |
|
Description: Dopamine HCl is a catecholamine neurotransmitter present in a wide variety of animals,And a dopamine D1-5 receptors agonist. |
|||
Dopamine HCl |
|||
| B1482-S | ApexBio | Evaluation Sample | 97.2 EUR |
|
Description: Dopamine HCl is a catecholamine neurotransmitter present in a wide variety of animals,And a dopamine D1-5 receptors agonist. |
|||
PD128907 HCl |
|||
| B1491-10 | ApexBio | 10 mg | 351.6 EUR |
|
Description: PD 128907 HCl is a potent and selective dopamine D3 receptor agonist, with EC50 of 0.64 nM, exhibits 53-fold selectivity over dopamine D2 receptor. |
|||
PD128907 HCl |
|||
| B1491-25 | ApexBio | 25 mg | 633.6 EUR |
|
Description: PD 128907 HCl is a potent and selective dopamine D3 receptor agonist, with EC50 of 0.64 nM, exhibits 53-fold selectivity over dopamine D2 receptor. |
|||
PD128907 HCl |
|||
| B1491-5 | ApexBio | 5 mg | 247.2 EUR |
|
Description: PD 128907 HCl is a potent and selective dopamine D3 receptor agonist, with EC50 of 0.64 nM, exhibits 53-fold selectivity over dopamine D2 receptor. |
|||
LP533401 hcl |
|||
| B5823-25 | ApexBio | 25 mg | 1312.8 EUR |
|
Description: LP533401 hcl is an inhibitor of Tph-1 [1]. Tryptophan hydroxylase-1 (Tph-1) is an isoenzyme of tryptophan hydroxylase and the initial enzyme in gut- and lung-derived serotonin biosynthesis. Tph-1 is mainly expressed in the gut and lung [2]. |
|||
LP533401 hcl |
|||
| B5823-5 | ApexBio | 5 mg | 547.2 EUR |
|
Description: LP533401 hcl is an inhibitor of Tph-1 [1]. Tryptophan hydroxylase-1 (Tph-1) is an isoenzyme of tryptophan hydroxylase and the initial enzyme in gut- and lung-derived serotonin biosynthesis. Tph-1 is mainly expressed in the gut and lung [2]. |
|||
Ambroxol HCl |
|||
| 20-abx076696 | Abbexa |
|
|
SKF38393 HCl |
|||
| B6030-100 | ApexBio | 100 mg | 192 EUR |
|
Description: SKF38393 HCl (SKF38393) is a selective dopamine D1 receptor agonist [1], with an IC50 value of 110 nM [2].There are two functional types of dopamine receptors, D1 and D2 receptors [3]. The stimulation of the D1 receptor (D1R) in prefrontal cortex (PFC) results in an ?inverted-U? dose-response. |
|||
SKF38393 HCl |
|||
| B6030-200 | ApexBio | 200 mg | 282 EUR |
|
Description: SKF38393 HCl (SKF38393) is a selective dopamine D1 receptor agonist [1], with an IC50 value of 110 nM [2].There are two functional types of dopamine receptors, D1 and D2 receptors [3]. The stimulation of the D1 receptor (D1R) in prefrontal cortex (PFC) results in an ?inverted-U? dose-response. |
|||
SKF38393 HCl |
|||
| B6030-500 | ApexBio | 500 mg | 547.2 EUR |
|
Description: SKF38393 HCl (SKF38393) is a selective dopamine D1 receptor agonist [1], with an IC50 value of 110 nM [2].There are two functional types of dopamine receptors, D1 and D2 receptors [3]. The stimulation of the D1 receptor (D1R) in prefrontal cortex (PFC) results in an ?inverted-U? dose-response. |
|||
Doxapram HCl |
|||
| A8419-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 170.4 EUR |
|
Description: Doxapram HCl is a respiratory stimulant. |
|||
Doxapram HCl |
|||
| A8419-50 | ApexBio | 50 mg | 157.2 EUR |
|
Description: Doxapram HCl is a respiratory stimulant. |
|||
Prazosin HCl |
|||
| A5318-100 | ApexBio | 100 mg | 199.2 EUR |
|
Description: ?1 and ?2B-adrenoceptor antagonist. Also a potent antagonist at the melatonin MT3 receptor (Ki = 10.2 nM). Also available as part of the ?1-Adrenoceptor Tocriset? and Mixed Adre |
|||
Prazosin HCl |
|||
| A5318-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: ?1 and ?2B-adrenoceptor antagonist. Also a potent antagonist at the melatonin MT3 receptor (Ki = 10.2 nM). Also available as part of the ?1-Adrenoceptor Tocriset? and Mixed Adre |
|||
Xylazine · HCl |
|||
| Q-1440.0025 | Bachem | 25.0g | 385.2 EUR |
|
Description: Sum Formula: C12H16N2S·HCl; CAS# [23076-35-9] |
|||
Dyclonine HCl |
|||
| B1936-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: Dyclonine is an oral anaesthetic found in Sucrets, an over the counter throat lozenge. |
|||
Dyclonine HCl |
|||
| B1936-50 | ApexBio | 50 mg | 153.6 EUR |
|
Description: Dyclonine is an oral anaesthetic found in Sucrets, an over the counter throat lozenge. |
|||
Dyclonine HCl |
|||
| B1936-S | ApexBio | Evaluation Sample | 97.2 EUR |
|
Description: Dyclonine is an oral anaesthetic found in Sucrets, an over the counter throat lozenge. |
|||
Guanidine HCl |
|||
| B1949-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: Guanidine HCl, the crystalline compound of strong alkalinity formed by the oxidation of guanine, is a normal product of protein metabolism and a protein denaturant. |
|||
Guanidine HCl |
|||
| B1949-50 | ApexBio | 50 mg | 153.6 EUR |
|
Description: Guanidine HCl, the crystalline compound of strong alkalinity formed by the oxidation of guanine, is a normal product of protein metabolism and a protein denaturant. |
|||
Naftifine HCl |
|||
| B1984-50 | ApexBio | 50 mg | 166.8 EUR |
|
Description: Naftifine is an allylamine antifungal drug for the topical treatment of tinea pedis, tinea cruris, and tinea corporis, probably involves selectively blocking sterol biosynthesis via inhibition of the squalene 2,3-epoxidase enzyme. |
|||
Naftifine HCl |
|||
| B1984-500 | ApexBio | 500 mg | 711.6 EUR |
|
Description: Naftifine is an allylamine antifungal drug for the topical treatment of tinea pedis, tinea cruris, and tinea corporis, probably involves selectively blocking sterol biosynthesis via inhibition of the squalene 2,3-epoxidase enzyme. |
|||
Diltiazem HCl |
|||
| B2089-10 | ApexBio | 10 mg | 129.6 EUR |
|
Description: Diltiazem HCl |
|||
Diltiazem HCl |
|||
| B2089-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 135.6 EUR |
|
Description: Diltiazem HCl |
|||
Diltiazem HCl |
|||
| B2089-50 | ApexBio | 50 mg | 268.8 EUR |
|
Description: Diltiazem HCl |
|||
Diltiazem HCl |
|||
| B2089-S | ApexBio | Evaluation Sample | 97.2 EUR |
|
Description: Diltiazem HCl |
|||
Quinapril HCl |
|||
| B2207-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: Quinapril is a prodrug that belongs to the angiotensin-converting enzyme (ACE) inhibitor class of medications. |
|||
Quinapril HCl |
|||
| B2207-50 | ApexBio | 50 mg | 153.6 EUR |
|
Description: Quinapril is a prodrug that belongs to the angiotensin-converting enzyme (ACE) inhibitor class of medications. |
|||
Quinapril HCl |
|||
| B2207-S | ApexBio | Evaluation Sample | 97.2 EUR |
|
Description: Quinapril is a prodrug that belongs to the angiotensin-converting enzyme (ACE) inhibitor class of medications. |
|||
Moexipril HCl |
|||
| B2212-100 | ApexBio | 100 mg | 381.6 EUR |
|
Description: Moexipril HCl is a potent orally active non-sulfhydryl angiotensin converting enzyme(ACE) inhibitor, which is used for the treatment of hypertension and congestive heart failure. |
|||
Moexipril HCl |
|||
| B2212-25 | ApexBio | 25 mg | 176.4 EUR |
|
Description: Moexipril HCl is a potent orally active non-sulfhydryl angiotensin converting enzyme(ACE) inhibitor, which is used for the treatment of hypertension and congestive heart failure. |
|||
Moexipril HCl |
|||
| B2212-50 | ApexBio | 50 mg | 235.2 EUR |
|
Description: Moexipril HCl is a potent orally active non-sulfhydryl angiotensin converting enzyme(ACE) inhibitor, which is used for the treatment of hypertension and congestive heart failure. |
|||
Trazodone HCl |
|||
| B2230-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: Trazodone HCl is an antidepressant belonging to the class of serotonin receptor antagonists and reuptake inhibitors for treatment of anxiety disorders.Trazodone is a triazolopyridine derivative, chemically and pharmacologically unrelated to other currentl |
|||
Trazodone HCl |
|||
| B2230-50 | ApexBio | 50 mg | 153.6 EUR |
|
Description: Trazodone HCl is an antidepressant belonging to the class of serotonin receptor antagonists and reuptake inhibitors for treatment of anxiety disorders.Trazodone is a triazolopyridine derivative, chemically and pharmacologically unrelated to other currentl |
|||
Azasetron HCl |
|||
| B2233-10 | ApexBio | 10 mg | 236.4 EUR |
|
Description: Azasetron Hydrochloride is a 5-HT3 receptor antagonist which is used as an anti-emetic.Azasetron inhibited the specific binding of [3H]quipazine to 5-HT3 receptors at the synaptic membranes of the rat cerebral cortex with a Ki value of 2.9 nM. Azasetron |
|||
Azasetron HCl |
|||
| B2233-100 | ApexBio | 100 mg | 1261.2 EUR |
|
Description: Azasetron Hydrochloride is a 5-HT3 receptor antagonist which is used as an anti-emetic.Azasetron inhibited the specific binding of [3H]quipazine to 5-HT3 receptors at the synaptic membranes of the rat cerebral cortex with a Ki value of 2.9 nM. Azasetron |
|||
Azasetron HCl |
|||
| B2233-200 | ApexBio | 200 mg | 1663.2 EUR |
|
Description: Azasetron Hydrochloride is a 5-HT3 receptor antagonist which is used as an anti-emetic.Azasetron inhibited the specific binding of [3H]quipazine to 5-HT3 receptors at the synaptic membranes of the rat cerebral cortex with a Ki value of 2.9 nM. Azasetron |
|||
Azasetron HCl |
|||
| B2233-5.1 | ApexBio | 10 mM (in 1mL H2O) | 271.2 EUR |
|
Description: Azasetron Hydrochloride is a 5-HT3 receptor antagonist which is used as an anti-emetic.Azasetron inhibited the specific binding of [3H]quipazine to 5-HT3 receptors at the synaptic membranes of the rat cerebral cortex with a Ki value of 2.9 nM. Azasetron |
|||
Azasetron HCl |
|||
| B2233-50 | ApexBio | 50 mg | 702 EUR |
|
Description: Azasetron Hydrochloride is a 5-HT3 receptor antagonist which is used as an anti-emetic.Azasetron inhibited the specific binding of [3H]quipazine to 5-HT3 receptors at the synaptic membranes of the rat cerebral cortex with a Ki value of 2.9 nM. Azasetron |
|||
Topotecan HCl |
|||
| B2296-10 | ApexBio | 10 mg | 115.2 EUR |
|
Description: Topotecan HCl?SKF104864?is an inhibitor of topoisomerase 1 and semisynthetic analogue of camptothecin [1].Topotecan HCl?SKF104864?has been reported to have a potent antitumor activity against tumors in murine models. |
|||
Topotecan HCl |
|||
| B2296-100 | ApexBio | 100 mg | 268.8 EUR |
|
Description: Topotecan HCl?SKF104864?is an inhibitor of topoisomerase 1 and semisynthetic analogue of camptothecin [1].Topotecan HCl?SKF104864?has been reported to have a potent antitumor activity against tumors in murine models. |
|||
Topotecan HCl |
|||
| B2296-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 135.6 EUR |
|
Description: Topotecan HCl?SKF104864?is an inhibitor of topoisomerase 1 and semisynthetic analogue of camptothecin [1].Topotecan HCl?SKF104864?has been reported to have a potent antitumor activity against tumors in murine models. |
|||
Topotecan HCl |
|||
| B2296-50 | ApexBio | 50 mg | 240 EUR |
|
Description: Topotecan HCl?SKF104864?is an inhibitor of topoisomerase 1 and semisynthetic analogue of camptothecin [1].Topotecan HCl?SKF104864?has been reported to have a potent antitumor activity against tumors in murine models. |
|||
Amprolium HCl |
|||
| B1663-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: Amprolium chloride is a thiamin antagonist, which prevents carbohydrate synthesis by blocking thiamine uptake. |
|||
Amprolium HCl |
|||
| B1663-50 | ApexBio | 50 mg | 153.6 EUR |
|
Description: Amprolium chloride is a thiamin antagonist, which prevents carbohydrate synthesis by blocking thiamine uptake. |
|||
Buspirone HCl |
|||
| B1687-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: Buspirone HCl |
|||
Buspirone HCl |
|||
| B1687-50 | ApexBio | 50 mg | 153.6 EUR |
|
Description: Buspirone HCl |
|||
Clonidine HCl |
|||
| B1333-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: Clonidine Hydrochloride is a centrally acting alpha-agonist hypotensive agent. |
|||
Clonidine HCl |
|||
| B1333-50 | ApexBio | 50 mg | 153.6 EUR |
|
Description: Clonidine Hydrochloride is a centrally acting alpha-agonist hypotensive agent. |
|||
Clonidine HCl |
|||
| B1333-S | ApexBio | Evaluation Sample | 97.2 EUR |
|
Description: Clonidine Hydrochloride is a centrally acting alpha-agonist hypotensive agent. |
|||
Ritodrine HCl |
|||
| B1347-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: Ritodrine HCl is a ?-2 adrenergic receptor agonist.Ritodrine is a tocolytic drug, used to stop premature labor. Ritodrine can significantly prolong a short interval more quickly but with relatively more side effects than magnesium sulphate. Stratified RCT |
|||
Ritodrine HCl |
|||
| B1347-50 | ApexBio | 50 mg | 153.6 EUR |
|
Description: Ritodrine HCl is a ?-2 adrenergic receptor agonist.Ritodrine is a tocolytic drug, used to stop premature labor. Ritodrine can significantly prolong a short interval more quickly but with relatively more side effects than magnesium sulphate. Stratified RCT |
|||
Ritodrine HCl |
|||
| B1347-S | ApexBio | Evaluation Sample | 97.2 EUR |
|
Description: Ritodrine HCl is a ?-2 adrenergic receptor agonist.Ritodrine is a tocolytic drug, used to stop premature labor. Ritodrine can significantly prolong a short interval more quickly but with relatively more side effects than magnesium sulphate. Stratified RCT |
|||
Betaxolol HCl |
|||
| B1353-10 | ApexBio | 10 mg | 129.6 EUR |
|
Description: Betaxolol is a ?1 adrenergic receptor blocker with IC50 of 6 ?M. |
|||
Betaxolol HCl |
|||
| B1353-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: Betaxolol is a ?1 adrenergic receptor blocker with IC50 of 6 ?M. |
|||
Betaxolol HCl |
|||
| B1353-50 | ApexBio | 50 mg | 226.8 EUR |
|
Description: Betaxolol is a ?1 adrenergic receptor blocker with IC50 of 6 ?M. |
|||
Betaxolol HCl |
|||
| B1353-S | ApexBio | Evaluation Sample | 97.2 EUR |
|
Description: Betaxolol is a ?1 adrenergic receptor blocker with IC50 of 6 ?M. |
|||
Terazosin HCl |
|||
| B1365-250 | ApexBio | 250 mg | 268.8 EUR |
|
Description: Terazosin HCl dihydrate is a selective alpha1-antagonist used for treatment of symptoms of benign prostatic hyperplasia (BPH). |
|||
Terazosin HCl |
|||
| B1365-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: Terazosin HCl dihydrate is a selective alpha1-antagonist used for treatment of symptoms of benign prostatic hyperplasia (BPH). |
|||
Terazosin HCl |
|||
| B1365-50 | ApexBio | 50 mg | 129.6 EUR |
|
Description: Terazosin HCl dihydrate is a selective alpha1-antagonist used for treatment of symptoms of benign prostatic hyperplasia (BPH). |
|||
Terazosin HCl |
|||
| B1365-S | ApexBio | Evaluation Sample | 97.2 EUR |
|
Description: Terazosin HCl dihydrate is a selective alpha1-antagonist used for treatment of symptoms of benign prostatic hyperplasia (BPH). |
|||
Buclizine HCl |
|||
| B1546-50 | ApexBio | 50 mg | 153.6 EUR |
|
Description: Buclizine HCL is an antihistamine and anticholinergic of the piperazine derivative family. |
|||
EPZ004777 HCl |
|||
| B1581-5 | ApexBio | 5 mg | 212.4 EUR |
|
Description: EPZ004777 is a potent and selective inhibitor of DOT1L, a protein methyltransferase catalyzing the methylation of lysine 4 of histone H3 (H3K4), with the half maximal inhibition concentration IC50 value of 400 pM [1]. |
|||
EPZ004777 HCl |
|||
| B1581-50 | ApexBio | 50 mg | 825.6 EUR |
|
Description: EPZ004777 is a potent and selective inhibitor of DOT1L, a protein methyltransferase catalyzing the methylation of lysine 4 of histone H3 (H3K4), with the half maximal inhibition concentration IC50 value of 400 pM [1]. |
|||
Biperiden HCl |
|||
| B1598-100 | ApexBio | 100 mg | 495.6 EUR |
|
Description: Biperiden HCl is an anticholinergic drug [1].As an anticholinergic drug, biperiden is first used in the treatment of Parkinson's disease. It is a competitive antagonist of muscarinic receptor. |
|||
Biperiden HCl |
|||
| B1598-25 | ApexBio | 25 mg | 176.4 EUR |
|
Description: Biperiden HCl is an anticholinergic drug [1].As an anticholinergic drug, biperiden is first used in the treatment of Parkinson's disease. It is a competitive antagonist of muscarinic receptor. |
|||
Biperiden HCl |
|||
| B1598-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 184.8 EUR |
|
Description: Biperiden HCl is an anticholinergic drug [1].As an anticholinergic drug, biperiden is first used in the treatment of Parkinson's disease. It is a competitive antagonist of muscarinic receptor. |
|||
Biperiden HCl |
|||
| B1598-500 | ApexBio | 500 mg | 860.4 EUR |
|
Description: Biperiden HCl is an anticholinergic drug [1].As an anticholinergic drug, biperiden is first used in the treatment of Parkinson's disease. It is a competitive antagonist of muscarinic receptor. |
|||
Donepezil HCl |
|||
| B1602-1000 | ApexBio | 1 g | 162 EUR |
|
Description: Donepezil Hydrochloride (Donepezil HCL) is a novel, potent and selective inhibitor of acetylcholinesterase (AChE), an enzyme possibly involved in cognitive dysfunction of patients suffering Alzheimer?s disease (AD), with the half maximal inhibition concentration IC50 value of 6.7 nM [1]. |
|||
Donepezil HCl |
|||
| B1602-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 135.6 EUR |
|
Description: Donepezil Hydrochloride (Donepezil HCL) is a novel, potent and selective inhibitor of acetylcholinesterase (AChE), an enzyme possibly involved in cognitive dysfunction of patients suffering Alzheimer?s disease (AD), with the half maximal inhibition concentration IC50 value of 6.7 nM [1]. |
|||
Donepezil HCl |
|||
| B1602-5000 | ApexBio | 5 g | 370.8 EUR |
|
Description: Donepezil Hydrochloride (Donepezil HCL) is a novel, potent and selective inhibitor of acetylcholinesterase (AChE), an enzyme possibly involved in cognitive dysfunction of patients suffering Alzheimer?s disease (AD), with the half maximal inhibition concentration IC50 value of 6.7 nM [1]. |
|||
Labetalol HCl |
|||
| B4795-100 | ApexBio | 100 mg | 142.8 EUR |
Labetalol HCl |
|||
| B4795-200 | ApexBio | 200 mg | 199.2 EUR |
Labetalol HCl |
|||
| B4795-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 142.8 EUR |
SCH772984 HCl |
|||
| B5866-10 | ApexBio | 10 mg | 309.6 EUR |
|
Description: SCH772984 HCl |
|||
SCH772984 HCl |
|||
| B5866-25 | ApexBio | 25 mg | 560.4 EUR |
|
Description: SCH772984 HCl |
|||
SCH772984 HCl |
|||
| B5866-5 | ApexBio | 5 mg | 226.8 EUR |
|
Description: SCH772984 HCl |
|||
SCH772984 HCl |
|||
| B5866-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 574.8 EUR |
|
Description: SCH772984 HCl |
|||
SCH772984 HCl |
|||
| B5866-50 | ApexBio | 50 mg | 950.4 EUR |
|
Description: SCH772984 HCl |
|||
Carteolol HCl |
|||
| B5944-100 | ApexBio | 100 mg | 1034.4 EUR |
|
Description: Beta-adrenergic antagonist are an important class of drugs for the treatment of various heart diseases, such as high blood pressure, insufficiency of blood flow to the heart muscle, irregular heart beat, thickened heart muscle, and decreased ability of the heart to empty or fill normally. |
|||
Carteolol HCl |
|||
| B5944-25 | ApexBio | 25 mg | 547.2 EUR |
|
Description: Beta-adrenergic antagonist are an important class of drugs for the treatment of various heart diseases, such as high blood pressure, insufficiency of blood flow to the heart muscle, irregular heart beat, thickened heart muscle, and decreased ability of the heart to empty or fill normally. |
|||
Carteolol HCl |
|||
| B5944-5 | ApexBio | 5 mg | 254.4 EUR |
|
Description: Beta-adrenergic antagonist are an important class of drugs for the treatment of various heart diseases, such as high blood pressure, insufficiency of blood flow to the heart muscle, irregular heart beat, thickened heart muscle, and decreased ability of the heart to empty or fill normally. |
|||
Carteolol HCl |
|||
| B5944-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 268.8 EUR |
|
Description: Beta-adrenergic antagonist are an important class of drugs for the treatment of various heart diseases, such as high blood pressure, insufficiency of blood flow to the heart muscle, irregular heart beat, thickened heart muscle, and decreased ability of the heart to empty or fill normally. |
|||
Donepezil HCl |
|||
| 27619-1 | BPS Bioscience | 1 g | 145 EUR |
Donepezil HCl |
|||
| 27619-2 | BPS Bioscience | 5 g | 305 EUR |
LY2606368 HCl |
|||
| B8313-25 | ApexBio | 25 mg | 978 EUR |
|
Description: LY2606368 HCl is a selective ATP competitive inhibitor of checkpoint kinase 1(CHK1) with IC50 value of 1.5nM in SW1990 cells [1].CHK1 is an intracellular serine/threonine kinase that plays a role in DNA damage response pathway. |
|||
LY2606368 HCl |
|||
| B8313-5 | ApexBio | 5 mg | 366 EUR |
|
Description: LY2606368 HCl is a selective ATP competitive inhibitor of checkpoint kinase 1(CHK1) with IC50 value of 1.5nM in SW1990 cells [1].CHK1 is an intracellular serine/threonine kinase that plays a role in DNA damage response pathway. |
|||
Mianserin HCl |
|||
| A1796-100 | ApexBio | 100 mg | 338.4 EUR |
|
Description: Non-selective 5-HT2 receptor antagonist. Has moderate affinity for 5-HT6. Antidepressant. |
|||
Mianserin HCl |
|||
| A1796-5 | ApexBio | 5 mg | 129.6 EUR |
|
Description: Non-selective 5-HT2 receptor antagonist. Has moderate affinity for 5-HT6. Antidepressant. |
|||
Mianserin HCl |
|||
| A1796-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 151.2 EUR |
|
Description: Non-selective 5-HT2 receptor antagonist. Has moderate affinity for 5-HT6. Antidepressant. |
|||
Puromycin HCl |
|||
| 20-abx076662 | Abbexa |
|
|
Guanidine Hcl |
|||
| abx082517-500g | Abbexa | 500 g | 226.8 EUR |
Verapamil HCl |
|||
| 20-abx076503 | Abbexa |
|
|
Tedizolid HCl |
|||
| B6049-10 | ApexBio | 10 mg | 309.6 EUR |
|
Description: IC50: for MAO-A (monoamine oxidase-A), 8.7 uM; for MAO-B, 5.7 uM.Tedizolid HCl is a reversible, novel oxazolidinone antibiotic. It is the first oxazolidinone to be approved since linezolid in 2000. |
|||
Tedizolid HCl |
|||
| B6049-5 | ApexBio | 5 mg | 226.8 EUR |
|
Description: IC50: for MAO-A (monoamine oxidase-A), 8.7 uM; for MAO-B, 5.7 uM.Tedizolid HCl is a reversible, novel oxazolidinone antibiotic. It is the first oxazolidinone to be approved since linezolid in 2000. |
|||
Tedizolid HCl |
|||
| B6049-50 | ApexBio | 50 mg | 783.6 EUR |
|
Description: IC50: for MAO-A (monoamine oxidase-A), 8.7 uM; for MAO-B, 5.7 uM.Tedizolid HCl is a reversible, novel oxazolidinone antibiotic. It is the first oxazolidinone to be approved since linezolid in 2000. |
|||
Pramoxine HCl |
|||
| B1819-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 142.8 EUR |
|
Description: Pramoxine is a topical local anesthetic that has been shown to have antipruritic properties. |
|||
Pramoxine HCl |
|||
| B1819-50 | ApexBio | 50 mg | 153.6 EUR |
|
Description: Pramoxine is a topical local anesthetic that has been shown to have antipruritic properties. |
|||
Serotonin HCl |
|||
| B1830-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 142.8 EUR |
|
Description: Serotonin HCl is a monoamine neurotransmitter and Endogenous 5-HT receptor agonist. |
|||
Serotonin HCl |
|||
| B1830-50 | ApexBio | 50 mg | 129.6 EUR |
|
Description: Serotonin HCl is a monoamine neurotransmitter and Endogenous 5-HT receptor agonist. |
|||
Sevelamer HCl |
|||
| B1833-50 | ApexBio | 50 mg | 153.6 EUR |
|
Description: Sevelamer HCl |
|||
Verapamil HCl |
|||
| B1867-1000 | ApexBio | 1 g | 150 EUR |
|
Description: Verapamil is an L-type calcium channel blocker of thephenylalkylamine class. |
|||
Verapamil HCl |
|||
| B1867-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 135.6 EUR |
|
Description: Verapamil is an L-type calcium channel blocker of thephenylalkylamine class. |
|||
Moreover, a number of different compounds are recognized (e.g., ethanol) that correlate with inhabitants density and originate from a number of VCP sources. Ethanol and fragrances are amongst the most considerable and reactive VOCs related to VCP emissions.